Author Correction: Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis

Antoine Roquilly; Cedric Jacqueline; Marion Davieau; Alice Mollé; Abderrahmane Sadek; Cynthia Fourgeux; Paul Rooze; Alexis Broquet; Barbara Misme-Aucouturier; Tanguy Chaumette; Mickael Vourc'h; Raphael Cinotti; Nadege Marec; Vanessa Gauttier; Hamish E G McWilliam; Frederic Altare; Jeremie Poschmann; Jose A Villadangos; Karim Asehnoune

doi:10.1038/s41590-020-0739-9

Author Correction: Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis

Nat Immunol. 2020 Aug;21(8):962. doi: 10.1038/s41590-020-0739-9.

Authors

Antoine Roquilly^#^{1

2

3}, Cedric Jacqueline^#⁴, Marion Davieau⁴, Alice Mollé⁵, Abderrahmane Sadek^{5

6}, Cynthia Fourgeux⁵, Paul Rooze^{4

7}, Alexis Broquet⁴, Barbara Misme-Aucouturier⁴, Tanguy Chaumette⁴, Mickael Vourc'h^{4

7}, Raphael Cinotti⁷, Nadege Marec⁸, Vanessa Gauttier⁵, Hamish E G McWilliam^{9

10}, Frederic Altare¹¹, Jeremie Poschmann¹², Jose A Villadangos¹³, Karim Asehnoune^{14

15}

Affiliations

¹ Université de Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Nantes, France. antoine.roquilly@chu-nantes.fr.
² Université de Nantes, CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Nantes, France. antoine.roquilly@chu-nantes.fr.
³ Department of Microbiology and Immunology, Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia. antoine.roquilly@chu-nantes.fr.
⁴ Université de Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Nantes, France.
⁵ Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR1064, ITUN, Nantes, France.
⁶ Department of Biology, Faculty of Science, Moulay Ismail University, Zitoune, Meknes, Morocco.
⁷ Université de Nantes, CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Nantes, France.
⁸ Plateforme Cytocell, SFR François Bonamy, Nantes, France.
⁹ Department of Microbiology and Immunology, Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.
¹⁰ Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
¹¹ CRCINA, INSERM, Université de Nantes, CHU de Nantes, Nantes, France.
¹² Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR1064, ITUN, Nantes, France. jeremie.poschmann@inserm.fr.
¹³ Department of Microbiology and Immunology, Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia. j.villadangos@unimelb.edu.au.
¹⁴ Université de Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Nantes, France. karim.asehnoune@chu-nantes.fr.
¹⁵ Université de Nantes, CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Nantes, France. karim.asehnoune@chu-nantes.fr.

^# Contributed equally.

PMID: 32581370
DOI: 10.1038/s41590-020-0739-9

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum